During the last session, Sionna Therapeutics Inc (NASDAQ:SION)’s traded shares were 0.19 million. At the end of the trading day, the stock’s price was $11.07, reflecting an intraday gain of 10.70% or $1.07. The 52-week high for the SION share is $25.19, that puts it down -127.55 from that peak though still a striking 34.42% gain since the share price plummeted to a 52-week low of $7.26. The company’s market capitalization is $488.45M, and the average intraday trading volume over the past 10 days was 0.16 million shares, and the average trade volume was 253.18K shares over the past three months.

Sionna Therapeutics Inc (NASDAQ:SION) trade information

Sionna Therapeutics Inc (SION) registered a 10.70% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.70% in intraday trading to $11.07, hitting a weekly high. The stock’s 5-day price performance is 44.52%, and it has moved by -20.24% in 30 days. The short interest in Sionna Therapeutics Inc (NASDAQ:SION) is 2.28 million shares and it means that shorts have 9.38 day(s) to cover.

The consensus price target of analysts on Wall Street is $45, which implies an increase of 75.4% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $45 and $45 respectively. As a result, SION is trading at a discount of -306.5% off the target high and -306.5% off the low.

While earnings are projected to return 86.26% in 2025, the next five years will return 45.72% per annum.

SION Dividends

Sionna Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-19. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Sionna Therapeutics Inc (NASDAQ:SION)’s Major holders

Sionna Therapeutics Inc insiders own 7.20% of total outstanding shares while institutional holders control 68.21%, with the float percentage being 73.51%.